PD04-07 HIGHER PD-L1 MRNA LEVEL IN CLEAR CELL RENAL CELL CARCINOMAS IS ASSOCIATED WITH A FAVORABLE OUTCOME
Xianghui Ning,Yanqing Gong,Shiming He,Teng Li,Jiangyi Wang,Shuanghe Peng,Jinchao Chen,Jiayuan Liu,Nienie Qi,Yinglu Guo,Kan Gong
DOI: https://doi.org/10.1016/j.juro.2017.02.226
2017-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Advanced (including Drug Therapy) I1 Apr 2017PD04-07 HIGHER PD-L1 MRNA LEVEL IN CLEAR CELL RENAL CELL CARCINOMAS IS ASSOCIATED WITH A FAVORABLE OUTCOME Xianghui Ning, Yanqing Gong, Shiming He, Teng Li, Jiangyi Wang, Shuanghe Peng, Jinchao Chen, Jiayuan Liu, Nienie Qi, Yinglu Guo, and Kan Gong Xianghui NingXianghui Ning More articles by this author , Yanqing GongYanqing Gong More articles by this author , Shiming HeShiming He More articles by this author , Teng LiTeng Li More articles by this author , Jiangyi WangJiangyi Wang More articles by this author , Shuanghe PengShuanghe Peng More articles by this author , Jinchao ChenJinchao Chen More articles by this author , Jiayuan LiuJiayuan Liu More articles by this author , Nienie QiNienie Qi More articles by this author , Yinglu GuoYinglu Guo More articles by this author , and Kan GongKan Gong More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.226AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Renal cell carcinoma (RCC) is one of the most common urological tumors. The role of programmed cell death 1 ligand 1 (PD-L1) in RCCs in predicting outcome of the patients is yet unclear. METHODS We analyzed the clinical and RNA-seq data of 522 kidney clear cell cancer (KIRC), 259 kidney papillary cell carcinoma (KIRP) and 66 kidney chromophobe (KICH) patients from The Cancer Genome Atlas (TCGA) database. RESULTS In KIRC patients with high PD-L1 mRNA level and low PD-L1 mRNA level in tumors, the median overall survival periods were 45.0 and 37.1 months respectively (p=0.002). Multivariate Cox regression tests found that PD-L1 mRNA level in tumor was an independent predictor for overall survival status in KIRC patients (HR=0.7, 95% CI 0.5-0.9, p=0.007). However, no significant difference in overall survival status was found between high and low PD-L1 groups in KIRP and KICH cohorts.Gene-set enrichment analysis on the data from databases of TCGA and GSE53757 dataset in GEO showed that several pathways relating to immunological functions were activated in KIRCs with high PD-L1 mRNA expression, and glycolysis and epithelial-mesenchymal transition pathways relating to tumor progression and metastasis were up-regulated in KIRCs with low PD-L1 mRNA level. CONCLUSIONS In conclusion, higher PD-L1 mRNA level in KIRC tissues was associated with a favorable outcome due to the higher immunological responses in tumor tissues. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e65 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Xianghui Ning More articles by this author Yanqing Gong More articles by this author Shiming He More articles by this author Teng Li More articles by this author Jiangyi Wang More articles by this author Shuanghe Peng More articles by this author Jinchao Chen More articles by this author Jiayuan Liu More articles by this author Nienie Qi More articles by this author Yinglu Guo More articles by this author Kan Gong More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...